Is Weight Loss-Induced Muscle Mass Loss Clinically Relevant?

JAMA. 2024 Jul 2;332(1):9-10. doi: 10.1001/jama.2024.6586.
No abstract available

Plain language summary

This Viewpoint explores the effects of weight loss achieved through GLP-1–based antiobesity medications on weight regain, fat-free mass, and skeletal muscle mass in people with obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Composition
  • Female
  • Humans
  • Male
  • Muscle, Skeletal* / pathology
  • Obesity* / complications
  • Sarcopenia* / etiology
  • Weight Loss*